Tags

Type your tag names separated by a space and hit enter

Therapeutic potential of Panax ginseng and its constituents, ginsenosides and gintonin, in neurological and neurodegenerative disorders: a patent review.
Expert Opin Ther Pat. 2019 01; 29(1):55-72.EO

Abstract

INTRODUCTION

Ginseng, Panax ginseng, has been used for various diseases and proven its great efficacy in managing central nervous system diseases.

AREAS COVERED

This article covers the therapeutic potential of patents on ginseng and its active constituents to develop therapies for neurodegenerative and neurological disorders, since 2010. The literature review was provided using multiple search engines including Google Patent, Espacenet and US Patent in the field of neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, cognitive, and neurological disorders.

EXPERT OPINION

The gathered data represented outstanding merits of ginseng in treatment of neurodegenerative and neurological disorders. These effects have been mediated by neurogenesis, anti-apoptotic and antioxidant properties, inhibition of mitochondrial dysfunction, receptor-operated Ca2+ channels, amyloid beta aggregation, and microglial activation as well as neurotransmitters modulation. However, these compounds have limited clinical application of for the prevention or treatment of neurodegenerative and neurological disorders. This might be due to incomplete data on their clinical pharmacokinetic and toxicity properties, and limited economic investments. There is an increasing trend in use of herbal medicines instead of chemical drugs, so it is time to make more attention to the application of ginseng, the grandfather of medicinal plants, from basic sciences to patients' bed.

Authors+Show Affiliations

a Pharmacological Research Center of Medicinal Plants, Faculty of Medicine , Mashhad University of Medical Sciences , Mashhad , Iran. b Department of Pharmacology, Faculty of Medicine , Mashhad University of Medical Sciences , Mashhad , Iran.c Pharmaceutical Research Center, Pharmaceutical Technology Institute , Mashhad University of Medical Sciences , Mashhad , Iran.c Pharmaceutical Research Center, Pharmaceutical Technology Institute , Mashhad University of Medical Sciences , Mashhad , Iran. d Pharmacodynamics and Toxicology Department , School of Pharmacy, Mashhad University of Medical Sciences , Mashhad , Iran.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

30513224

Citation

Rajabian, Arezoo, et al. "Therapeutic Potential of Panax Ginseng and Its Constituents, Ginsenosides and Gintonin, in Neurological and Neurodegenerative Disorders: a Patent Review." Expert Opinion On Therapeutic Patents, vol. 29, no. 1, 2019, pp. 55-72.
Rajabian A, Rameshrad M, Hosseinzadeh H. Therapeutic potential of Panax ginseng and its constituents, ginsenosides and gintonin, in neurological and neurodegenerative disorders: a patent review. Expert Opin Ther Pat. 2019;29(1):55-72.
Rajabian, A., Rameshrad, M., & Hosseinzadeh, H. (2019). Therapeutic potential of Panax ginseng and its constituents, ginsenosides and gintonin, in neurological and neurodegenerative disorders: a patent review. Expert Opinion On Therapeutic Patents, 29(1), 55-72. https://doi.org/10.1080/13543776.2019.1556258
Rajabian A, Rameshrad M, Hosseinzadeh H. Therapeutic Potential of Panax Ginseng and Its Constituents, Ginsenosides and Gintonin, in Neurological and Neurodegenerative Disorders: a Patent Review. Expert Opin Ther Pat. 2019;29(1):55-72. PubMed PMID: 30513224.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Therapeutic potential of Panax ginseng and its constituents, ginsenosides and gintonin, in neurological and neurodegenerative disorders: a patent review. AU - Rajabian,Arezoo, AU - Rameshrad,Maryam, AU - Hosseinzadeh,Hossein, Y1 - 2018/12/11/ PY - 2018/12/5/pubmed PY - 2019/1/29/medline PY - 2018/12/5/entrez KW - Alzheimer’s disease KW - Panax ginseng KW - Parkinson’s disease KW - Patent KW - ginsenoside KW - neuroprotective SP - 55 EP - 72 JF - Expert opinion on therapeutic patents JO - Expert Opin Ther Pat VL - 29 IS - 1 N2 - INTRODUCTION: Ginseng, Panax ginseng, has been used for various diseases and proven its great efficacy in managing central nervous system diseases. AREAS COVERED: This article covers the therapeutic potential of patents on ginseng and its active constituents to develop therapies for neurodegenerative and neurological disorders, since 2010. The literature review was provided using multiple search engines including Google Patent, Espacenet and US Patent in the field of neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, cognitive, and neurological disorders. EXPERT OPINION: The gathered data represented outstanding merits of ginseng in treatment of neurodegenerative and neurological disorders. These effects have been mediated by neurogenesis, anti-apoptotic and antioxidant properties, inhibition of mitochondrial dysfunction, receptor-operated Ca2+ channels, amyloid beta aggregation, and microglial activation as well as neurotransmitters modulation. However, these compounds have limited clinical application of for the prevention or treatment of neurodegenerative and neurological disorders. This might be due to incomplete data on their clinical pharmacokinetic and toxicity properties, and limited economic investments. There is an increasing trend in use of herbal medicines instead of chemical drugs, so it is time to make more attention to the application of ginseng, the grandfather of medicinal plants, from basic sciences to patients' bed. SN - 1744-7674 UR - https://www.unboundmedicine.com/medline/citation/30513224/Therapeutic_potential_of_Panax_ginseng_and_its_constituents_ginsenosides_and_gintonin_in_neurological_and_neurodegenerative_disorders:_a_patent_review_ L2 - https://www.tandfonline.com/doi/full/10.1080/13543776.2019.1556258 DB - PRIME DP - Unbound Medicine ER -